Rapport Therapeutics, Inc. Common Stock (RAPP) earnings · $532.9M cap
These earnings events as JSON? API free 100/dayRapport Therapeutics, Inc. Common Stock (RAPP) is a biotechnology company listed on US.
This RAPP earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported RAPP revenue for 2026-06-30 was $0. Net income was -$56.6M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. RAPP currently screens at market cap $532.9M.
When the next RAPP 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 100.0% from 2026-03-31 to 2026-06-30. An earnings headline that ignores that move is noise.
Not investment advice. Full RAPP research stays on the stock page; the tape stays on the quote page.
RAPP earnings FAQ
What is RAPP's latest net income?
Latest cached Rapport Therapeutics, Inc. Common Stock (RAPP) net income was -$56.6M. Statements: https://lician.com/financials/rapp
What is RAPP's latest diluted EPS?
Latest cached Rapport Therapeutics, Inc. Common Stock (RAPP) diluted EPS for Jun 30, 2026 was -$1.19.
What period does the latest RAPP earnings print cover?
The latest cached Rapport Therapeutics, Inc. Common Stock (RAPP) earnings print covers Jun 30, 2026. The prior cached period on this page is Mar 31, 2026.
Where are RAPP earnings listed?
Cached earnings facts for Rapport Therapeutics, Inc. Common Stock (RAPP) are listed at https://lician.com/earnings/rapp. Statements: https://lician.com/financials/rapp
Not investment advice.